Unfractionated heparin (UFH) is a widely used anticoagulant, particularly in critical care settings, to prevent and treat thromboembolic disorders. Monitoring UFH therapy is crucial to ensure ...

There are two formulations of heparins, unfractionated heparin (UFH) and low molecular weight heparin (LMWH), used in clinical practice. Unfractionated heparin is used for both therapeutic ...

BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

For patients with either NSTEMI or STEMI, American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that intravenous unfractionated heparin (UFH) be dosed by weight ...

While similar in mechanism to unfractionated heparin, LMWH is cleared renally, has a much longer half-life and less commonly causes heparin-induced thrombocytopenia (HIT). Monitoring drug activity ...